SMTL ID : 5sfi.2 (3 other biounits)

Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-[2-methyl-5-(2-methylpyrrolidin-1-yl)-1,2,4-triazol-3-yl]ethyl]-[1,2,4]triazolo[1,5-a]pyrazine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.01 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 6 residues within 4Å: Chain A: H.79, H.83, H.117, D.118, D.228 Ligands: MG.2 6 PLIP interactions: 4 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:H.83, A:H.117, A:D.118, A:D.228, H2O.1, H2O.4

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 3 residues within 4Å: Chain A: D.118, E.146 Ligands: ZN.1 6 PLIP interactions: 1 interactions with chain A, 5 Ligand-Water interactions Metal complexes: A:D.118, H2O.1, H2O.2, H2O.4, H2O.4, H2O.4

1 x IKU: (4S)-5,8-dimethyl-2-(2-{1-methyl-3-[(2S)-2-methylpyrrolidin-1-yl]-1H-1,2,4-triazol-5-yl}ethyl)[1,2,4]triazolo[1,5-a]pyrazine(Non-covalent)

IKU.3: 13 residues within 4Å: Chain A: L.229, V.232, I.246, Y.247, F.250, P.266, M.267, K.272, E.275, V.276, G.279, Q.280, F.283 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.232, A:I.246, A:F.250, A:P.266, A:K.272, A:E.275, A:F.283 Hydrogen bonds: A:Y.247, A:Q.280 Water bridges: A:M.267 pi-Stacking: A:F.283, A:F.283

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tosstorff, A. et al., A high quality, industrial data set for binding affinity prediction: performance comparison in different early drug discovery scenarios. J.Comput.Aided Mol.Des. (2022)

Release Date

2022-10-12

Peptides

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A

Related Entries With Identical Sequence